Related Experiment Videos
Localization of a neutralization epitope of foot-and-mouth disease virus using neutralizing monoclonal antibodies
Abstract:
Neutralizing monoclonal antibodies raised against intact foot-and-mouth disease virus reacted with intact particles and with isolated VP1 from different strains from the same subtype. Prior treatment of the virus with either trypsin or with arginine-specific protease abolished recognition of both the virus and of VP1, suggesting the presence of a neutralization epitope in the central region of VP1 cleaved by these two enzymes. A synthetic peptide analogue of part of this region showed poor reactivity, however, with neutralizing antibody.
Insights
Neutralizing antibodies target foot-and-mouth disease virus (FMDV) and its VP1 protein. Protease treatment suggests a key neutralization site on VP1, but synthetic peptides showed limited antibody response.
Area of Science:
- Virology
- Immunology
- Structural Biology
Background:
- Foot-and-mouth disease virus (FMDV) is a significant threat to livestock.
- Understanding FMDV neutralization epitopes is crucial for vaccine development.
Purpose of the Study:
- To investigate the neutralization epitopes of FMDV recognized by monoclonal antibodies.
- To identify the specific viral protein and region involved in antibody recognition.
Main Methods:
- Monoclonal antibodies were generated against intact FMDV.
- Antibody reactivity was tested against intact virus and isolated VP1 protein.
- Enzymatic cleavage (trypsin, arginine-specific protease) was used to probe epitope accessibility.
Main Results:
- Neutralizing antibodies recognized both intact FMDV and isolated VP1 from various strains within the same subtype.
- Protease treatment of FMDV and VP1 abolished antibody binding, indicating an epitope in a protease-sensitive region.
- A synthetic peptide representing a portion of the central VP1 region showed poor reactivity with neutralizing antibodies.
Conclusions:
- A neutralization epitope is located in a protease-sensitive region of the FMDV VP1 protein.
- The conformational structure of the epitope is critical for antibody recognition, as suggested by the poor reactivity of the synthetic peptide.